Skip to main content
A delayed injection-site reaction in a patient receiving extended-release naltrexone.
Published Web Locationhttps://doi.org/10.1080/08897077.2016.1138919
BackgroundPharmacotherapy, such as oral naltrexone, has proven effective in treating alcohol use disorder, although medication adherence has presented challenges. Although a formulation of extended-release naltrexone for intramuscular injection has been developed to counter daily adherence issues, injection-site reactions can occur within days of depot injection.
CaseThe authors report a case of an individual with alcohol use disorder who had a previously undescribed delayed injection-site reaction that occurred 11 days after injection. Subsequent challenge with the medication resulted in recurrence of the reaction.
DiscussionAlthough extended-release naltrexone is generally well tolerated, injection-site reactions can complicate treatment and can appear more than 10 days after medication administration.
For improved accessibility of PDF content, download the file to your device.